BEX2 anticorps (AA 1-128) (HRP)

N° du produit ABIN7165130

Détail du produit anti-BEX2 anticorps (HRP)

Antigène: BEX2 (Brain Expressed X-Linked 2 (BEX2))

Épitope: AA 1-128

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BEX2 est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Protein BEX2 protein (1-128AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur BEX2

Antigène: BEX2 (Brain Expressed X-Linked 2 (BEX2))

Autre désignation: BEX2 (BEX2 Produits)

Synonymes: anticorps BEX1, anticorps DJ79P11.1, anticorps AL024066, anticorps Bex1, anticorps EG2RVC, anticorps brain expressed X-linked 2, anticorps BEX2, anticorps Bex2

Sujet:

Background: Regulator of mitochondrial apoptosis and G1 cell cycle in breast cancer. Protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of BCL2 protein family, which involves the positive regulation of anti-apoptotic member BCL2 and the negative regulation of pro-apoptotic members BAD, BAK1 and PUMA. Required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of CCND1 and CDKN1A. Regulates the level of PP2A regulatory subunit B and PP2A phosphatase activity.

Aliases: BEX2Protein BEX2 antibody, Brain-expressed X-linked protein 2 antibody, hBex2 antibody

UniProt: Q9BXY8